Immune responses to Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 20, Issue 19, 2014, Pages 5583-5593

  Moyat, Mati ^a   Velin, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Gastric cancer; Helicobacter pylori; Immune response; Peptic ulcer; Vaccine

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL CLEARANCE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC INFLAMMATION; DENDRITIC CELL; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; INTESTINE EPITHELIUM CELL; MICROFLORA; NONHUMAN; STOMACH BIOPSY; GASTRITIS; GASTROINTESTINAL TRACT; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MICROBIOLOGY; PEPTIC ULCER; STOMACH;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; GASTRITIS; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATION; PEPTIC ULCER; STOMACH;

EID: 84901196099     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i19.5583     Document Type: Article

References (126)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/ S0140-6736(84)91816-6]
2. Schreiber S, Konradt M, Groll C, Scheid P, Hanauer G, Werling HO, Josenhans C, Suerbaum S. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci USA 2004; 101: 5024-5029 [PMID: 15044704 DOI: 10.1073/pnas.0308386101]
3. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658-663 [PMID: 3950447 DOI: 10.1093/ infdis/153.4.658]
4. Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I, Dubois A. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003; 187: 1165-1177 [PMID: 12695995 DOI: 10.1086/368133]
5. Atherton JC, Tham KT, Peek RM, Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis 1996; 174: 552-556 [PMID: 8769613 DOI: 10.1093/infdis/174.3.552]
6. Bauerfeind P, Garner R, Dunn BE, Mobley HL. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 1997; 40: 25-30 [PMID: 9155571]
7. Wen Y, Feng J, Scott DR, Marcus EA, Sachs G. The HP0165-HP0166 two-component system (ArsRS) regulates acidinduced expression of HP1186 alpha-carbonic anhydrase in Helicobacter pylori by activating the pH-dependent promoter. J Bacteriol 2007; 189: 2426-2434 [PMID: 17220228 DOI: 10.1128/JB.01492-06]
8. Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun 1996; 64: 2445-2448 [PMID: 8698465]
9. Wiedemann T, Hofbaur S, Tegtmeyer N, Huber S, Sewald N, Wessler S, Backert S, Rieder G. Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin-integrin linked kinase signalling complex. Gut 2012; 61: 986-996 [PMID: 22287591 DOI: 10.1136/gutjnl-2011-300525]
10. Saha A, Backert S, Hammond CE, Gooz M, Smolka AJ. Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology 2010; 139: 239-248 [PMID: 20303353 DOI: 10.1053/ j.gastro.2010.03.036]
11. Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, Graham DY, van der Merwe S, Achtman M, Suerbaum S. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog 2008; 4: e1000180 [PMID: 18949030 DOI: 10.1371/journal.ppat.1000180]
12. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8 [PMID: 8040281 DOI: 10.1172/JCI117336]
13. Ford A, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2004; (4): CD003840 [PMID: 15495066 DOI: 10.1002/14651858.CD003840.pub2]
14. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397 [PMID: 18675689 DOI: 10.1016/ S0140-6736(08)61159-9]
15. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128: 1579-1605 [PMID: 15887153 DOI: 10.1053/j.gastro.2005.03.083]
16. Wolle K, Malfertheiner P. Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol 2007; 21: 315-324 [PMID: 17382279 DOI: 10.1016/j.bpg.2006.11.001]
17. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004; 53: 1235-1243 [PMID: 15306577 DOI: 10.1136/gut.2003.037499]
18. Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, Osato M, Estes MK, Graham DY. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005; 73: 2999-3006 [PMID: 15845507 DOI: 10.1128/IAI.73.5.2999-3006.2005]
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 [PMID: 8827022 DOI: 10.1097/00000478-199610000-00001]
20. Suzuki T, Kato K, Ohara S, Noguchi K, Sekine H, Nagura H, Shimosegawa T. Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathol Int 2002; 52: 265-271 [PMID: 12031081 DOI: 10.1046/j.1440-1827.2002.01347. x]
21. Terrés AM, Pajares JM. An increased number of follicles containing activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-infected gastric mucosa. Am J Gastroenterol 1998; 93: 579-583 [PMID: 9576451 DOI: 10.1111/j.1572-0241.1998.168_b.x]
22. Di Tommaso A, Xiang Z, Bugnoli M, Pileri P, Figura N, Bayeli PF, Rappuoli R, Abrignani S, De Magistris MT. Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect Immun 1995; 63: 1102-1106 [PMID: 7868233]
23. Lindholm C, Quiding-Järbrink M, Lönroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-5971 [PMID: 9826379]
24. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158: 962-967 [PMID: 8993017]
25. Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 2000; 165: 5332-5337 [PMID: 11046068]
26. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10: 479-489 [PMID: 20559326 DOI: 10.1038/nri2800]
27. Cooper AM. IL-17 and anti-bacterial immunity: protection versus tissue damage. Eur J Immunol 2009; 39: 649-652 [PMID: 19283706 DOI: 10.1002/eji.200839090]
28. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003; 71: 1755-1762 [PMID: 12654789 DOI: 10.1128/IAI.71.4.1755-1762.2003]
29. Raghavan S, Fredriksson M, Svennerholm AM, Holmgren J, Suri-Payer E. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 2003; 132: 393-400 [PMID: 12780684 DOI: 10.1046/ j.1365-2249.2003.02177.x]
30. Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Peña A, Rollán A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, Smith PD. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008; 134: 491-499 [PMID: 18242215 DOI: 10.1053/j.gastro.2007.11.006]
31. Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131: 525-537 [PMID: 16890606 DOI: 10.1053/j.gastro.2006.05.001]
32. Serrano C, Wright SW, Bimczok D, Shaffer CL, Cover TL, Venegas A, Salazar MG, Smythies LE, Harris PR, Smith PD. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunol 2013; 6: 950-959 [PMID: 23299619 DOI: 10.1038/ mi.2012.133]
33. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11-17 [PMID: 3288028 DOI: 10.7326/0003-4819-10 9-1-11]
34. Mattsson A, Quiding-Järbrink M, Lönroth H, Hamlet A, Ahlstedt I, Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 2705-2712 [PMID: 9596737]
35. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+, K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115: 340-347 [PMID: 9679039 DOI: 10.1016/S0016-5085(98)70200-8]
36. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol 2011; 29: 273-293 [PMID: 21219173 DOI: 10.1146/annurev-immunol-031210-101317]
37. Benveniste J, Lespinats G, Salomon J. Serum and secretory IgA in axenic and holoxenic mice. J Immunol 1971; 107: 1656-1662 [PMID: 4330459]
38. Benveniste J, Lespinats G, Adam C, Salomon JC. Immunoglobulins in intact, immunized, and contaminated axenic mice: study of serum IgA. J Immunol 1971; 107: 1647-1655 [PMID: 4330458]
39. Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 2004; 101: 1981-1986 [PMID: 14766966 DOI: 10.1073/ pnas.0307317101]
40. Kaneko T, Ota H, Hayama M, Akamatsu T, Katsuyama T. Helicobacter pylori infection produces expression of a secretory component in gastric mucous cells. Virchows Arch 2000; 437: 514-520 [PMID: 11147172]
41. Isaacson P. Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut 1982; 23: 578-588 [PMID: 7044912 DOI: 10.1136/gut.23.7.578]
42. Ahlstedt I, Lindholm C, Lönroth H, Hamlet A, Svennerholm AM, Quiding-Järbrink M. Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection. Infect Immun 1999; 67: 4921-4925 [PMID: 10456951]
43. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 2000; 68: 6265-6272 [PMID: 11035734 DOI: 10.1128/ IAI.68.11.6265-6272.2000]
44. Quiding-Järbrink M, Sundström P, Lundgren A, Hansson M, Bäckström M, Johansson C, Enarsson K, Hermansson M, Johnsson E, Svennerholm AM. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Clin Immunol 2009; 131: 463-471 [PMID: 19249247 DOI: 10.1016/j.clim.2009.01.010]
45. Birkholz S, Schneider T, Knipp U, Stallmach A, Zeitz M. Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients. Digestion 1998; 59: 638-645 [PMID: 9813386 DOI: 10.1159/000007568]
46. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288: 2222-2226 [PMID: 10864873 DOI: 10.1126/science.288.5474.2222]
47. Zimmermann K, Haas A, Oxenius A. Systemic antibody responses to gut microbes in health and disease. Gut Microbes 2012; 3: 42-47 [PMID: 22356852 DOI: 10.4161/gmic.19344]
48. Ben Suleiman Y, Yoshida M, Nishiumi S, Tanaka H, Mimura T, Nobutani K, Yamamoto K, Takenaka M, Aoganghua A, Miki I, Ota H, Takahashi S, Matsui H, Nakamura M, Blumberg RS, Azuma T. Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice. Mucosal Immunol 2012; 5: 87-98 [PMID: 22089027 DOI: 10.1038/mi.2011.53]
49. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054 [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043]
50. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclu-sively by dendritic cells in the draining lymph node. J Exp Med 2002; 196: 1079-1090 [PMID: 12391019 DOI: 10.1084/ jem.20020991]
51. Feng T, Elson CO. Adaptive immunity in the host-microbiota dialog. Mucosal Immunol 2011; 4: 15-21 [PMID: 20944557 DOI: 10.1038/mi.2010.60]
52. Konrad A, Cong Y, Duck W, Borlaza R, Elson CO. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 2006; 130: 2050-2059 [PMID: 16762628 DOI: 10.1053/j.gastro.2006.02.055]
53. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435-446 [PMID: 18500229 DOI: 10.1038/nri2335]
54. Rescigno M, Lopatin U, Chieppa M. Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr Opin Immunol 2008; 20: 669-675 [PMID: 18852045 DOI: 10.1016/j.coi.2008.09.007]
55. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009; 119: 2441-2450 [PMID: 19729841 DOI: 10.1172/JCI39134]
56. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6: 507-514 [PMID: 15821737 DOI: 10.1038/ni1192]
57. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 2005; 106: 2818-2826 [PMID: 16030185 DOI: 10.1182/blood-2004-11-4321]
58. Trejdosiewicz LK, Calabrese A, Smart CJ, Oakes DJ, Howdle PD, Crabtree JE, Losowsky MS, Lancaster F, Boylston AW. Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol 1991; 84: 440-444 [PMID: 1828397]
59. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D'Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013; 39: 372-385 [PMID: 23973224 DOI: 10.1016/ j.immuni.2013.08.003]
60. Lindgren Å, Yun CH, Sjöling Å, Berggren C, Sun JB, Jonsson E, Holmgren J, Svennerholm AM, Lundin SB. Impaired IFN-γ production after stimulation with bacterial components by natural killer cells from gastric cancer patients. Exp Cell Res 2011; 317: 849-858 [PMID: 21255568 DOI: 10.1016/ j.yexcr.2011.01.006]
61. Ismail HF, Fick P, Zhang J, Lynch RG, Berg DJ. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003; 170: 3782-3789 [PMID: 12646644]
62. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 2005; 129: 142-155 [PMID: 16012944 DOI: 10.1053/j.gastro.2005.04.010]
63. Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 2003; 71: 3628-3633 [PMID: 12761151 DOI: 10.1128/ IAI.71.6.3628-3633.2003]
64. Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol Suppl 1994; 205: 11-21 [PMID: 7863237 DOI: 10.3109/00365529409091404]
65. Ericksen RE, Rose S, Westphalen CB, Shibata W, Muthupalani S, Tailor Y, Friedman RA, Han W, Fox JG, Ferrante AW, Wang TC. Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. Gut 2014; 63: 385-394 [PMID: 23729675 DOI: 10.1136/gutjnl-2013-305092]
66. Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JY, Sung JJ, Ding C. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 2009; 4: e7985 [PMID: 19956741 DOI: 10.1371/journal.pone.0007985]
67. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006; 103: 732-737 [PMID: 16407106 DOI: 10.1073/pnas.0506655103]
68. Andersson AF, Lindberg M, Jakobsson H, Bäckhed F, Nyrén P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3: e2836 [PMID: 18665274 DOI: 10.1371/journal.pone.0002836]
69. Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 2013; 4: 505-531 [PMID: 23962822]
70. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336: 1268-1273 [PMID: 22674334 DOI: 10.1126/science. 1223490]
71. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-498 [PMID: 19836068 DOI: 10.1016/j.cell.2009.09.033]
72. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232-236 [PMID: 23842501 DOI: 10.1038/nature12331]
73. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-1286 [PMID: 19865172 DOI: 10.1038/nature08530]
74. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105: 16731-16736 [PMID: 18936492 DOI: 10.1073/ pnas.0804812105]
75. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, Amedei A, D'Elios MM, Telford JL, Baldari CT. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 2003; 198: 1887-1897 [PMID: 14676300 DOI: 10.1084/jem.20030621]
76. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301: 1099-1102 [PMID: 12934009 DOI: 10.1126/science.1086871]
77. Schmees C, Prinz C, Treptau T, Rad R, Hengst L, Voland P, Bauer S, Brenner L, Schmid RM, Gerhard M. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 2007; 132: 1820-1833 [PMID: 17484877 DOI: 10.1053/j.gastro.2007.02.031]
78. Zabaleta J, McGee DJ, Zea AH, Hernández CP, Rodriguez PC, Sierra RA, Correa P, Ochoa AC. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol 2004; 173: 586-593 [PMID: 15210820]
79. Simoons-Smit IM, Appelmelk BJ, Verboom T, Negrini R, Penner JL, Aspinall GO, Moran AP, Fei SF, Shi BS, Rudnica W, Savio A, de Graaff J. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J Clin Microbiol 1996; 34: 2196-2200 [PMID: 8862584]
80. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth HP, Kapsenberg ML, Vandenbroucke-Grauls CM, van Kooyk Y, Appelmelk BJ. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004; 200: 979-990 [PMID: 15492123 DOI: 10.1084/jem.20041061]
81. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 2000; 191: 115-128 [PMID: 10620610 DOI: 10.1084/ jem.191.1.115]
82. Ramarao N, Gray-Owen SD, Backert S, Meyer TF. Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol Microbiol 2000; 37: 1389-1404 [PMID: 10998171 DOI: 10.1046/ j.1365-2958.2000.02089.x]
83. Ramarao N, Gray-Owen SD, Meyer TF. Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol 2000; 38: 103-113 [PMID: 11029693 DOI: 10.1046/j.1365-2958.2000.02114.x]
84. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 2004; 189: 1914-1920 [PMID: 15122529 DOI: 10.1086/386289]
85. Suda Y, Kim YM, Ogawa T, Yasui N, Hasegawa Y, Kashihara W, Shimoyama T, Aoyama K, Nagata K, Tamura T, Kusumoto S. Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206. J Endotoxin Res 2001; 7: 95-104 [PMID: 11521089]
86. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740 [PMID: 1458460]
87. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990; 99: 1315-1323 [PMID: 2210240]
88. Marchetti M, Aricò B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-1658 [PMID: 7886456 DOI: 10.1126/science.7886456]
89. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112: 1386-1397 [PMID: 9098027 DOI: 10.1016/S0016-5085(97)70155-0]
90. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19: 523-563 [PMID: 11244046 DOI: 10.1146/annurev.immunol.19.1.523]
91. Dubois A, Fiala N, Heman-Ackah LM, Drazek ES, Tarnawski A, Fishbein WN, Perez-Perez GI, Blaser MJ. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 1994; 106: 1405-1417 [PMID: 8194685]
92. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998; 188: 2277-2288 [PMID: 9858514 DOI: 10.1084/ jem.188.12.2277]
93. Velin D, Bachmann D, Bouzourene H, Michetti P. Reduction of Helicobacter infection in IL-10-/-mice is dependent on CD4+ T cells but not on mast cells. Helicobacter 2008; 13: 361-369 [PMID: 19250511 DOI: 10.1111/j.1523-5378.2008.00614. x]
94. Lee CK, Weltzin R, Thomas WD, Kleanthous H, Ermak TH, Soman G, Hill JE, Ackerman SK, Monath TP. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995; 172: 161-172 [PMID: 7797906 DOI: 10.1093/infdis/172.1.161]
95. Gorrell RJ, Wijburg OL, Pedersen JS, Walduck AK, Kwok T, Strugnell RA, Robins-Browne RM. Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun 2013; 81: 3880-3893 [PMID: 23918779 DOI: 10.1128/IAI.01424-12]
96. Kleanthous H, Lee CK, Monath TP. Vaccine development against infection with Helicobacter pylori. Br Med Bull 1998; 54: 229-241 [PMID: 9604446 DOI: 10.1093/oxfordjournals. bmb.a011673]
97. Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA, Weaver LT. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993; 342: 121 [PMID: 8100892 DOI: 10.1016/0140-6736(93)91327-I]
98. Corthésy-Theulaz I, Corthésy B, Bachmann D, Velin D, Kraehenbuhl JP. Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning. Infect Immun 2003; 71: 2226-2229 [PMID: 12654845 DOI: 10.1128/IAI.71.4.2226-2229.2003]
99. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology 2000; 119: 109-118 [PMID: 10889160 DOI: 10.1053/gast.2000.8548]
100. Aebischer T, Laforsch S, Hurwitz R, Brombacher F, Meyer TF. Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice. Infect Immun 2001; 69: 556-558 [PMID: 11119552 DOI: 10.1128/IAI.69.1.556-558.2001]
101. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999; 67: 279-285 [PMID: 9864227]
102. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 2009; 136: 247-256 [PMID: 18948106 DOI: 10.1053/j.gastro.2008.09.017]
103. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009; 136: 2237-2246. e1 [PMID: 19272385 DOI: 10.1053/j.gastro.2009.02.077]
104. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476 [PMID: 15485625 DOI: 10.1016/j.immuni.2004.08.018]
105. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527 [PMID: 11514607 DOI: 10.1084/jem.194.4.519]
106. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11: 637-642 [PMID: 8322486 DOI: 10.1016/0264-410X(93)90309-L]
107. Doidge C, Crust I, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunisation against Helicobacter infection. Lancet 1994; 343: 914-915 [PMID: 7908372 DOI: 10.1016/ S0140-6736(94)90032-9]
108. Corthésy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney AC, Haas R, Kraehenbuhl JP, Blum AL, Michetti P. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995; 109: 115-121 [PMID: 7797009 DOI: 10.1016/001 6-5085(95)90275-9]
109. Ikewaki J, Nishizono A, Goto T, Fujioka T, Mifune K. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol 2000; 44: 29-39 [PMID: 10711597 DOI: 10.1111/j.1348-0421.2000.tb01243.x]
110. Gottwein JM, Blanchard TG, Targoni OS, Eisenberg JC, Zagorski BM, Redline RW, Nedrud JG, Tary-Lehmann M, Lehmann PV, Czinn SJ. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J Infect Dis 2001; 184: 308-314 [PMID: 11443556 DOI: 10.1086/322032]
111. Kipanyula MJ, Seke Etet PF, Vecchio L, Farahna M, Nukenine EN, Nwabo Kamdje AH. Signaling pathways bridging microbial-triggered inflammation and cancer. Cell Signal 2013; 25: 403-416 [PMID: 23123499 DOI: 10.1016/ j.cellsig.2012.10.014]
112. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198: 553-560 [PMID: 18598192 DOI: 10.1086/590158]
113. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, Müller A. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012; 122: 1082-1096 [PMID: 22307326 DOI: 10.1172/JCI61029]
114. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13: 260-270 [PMID: 22411464 DOI: 10.1038/nrg3182]
115. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Mémet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174 [PMID: 15489856 DOI: 10.1038/ni1131]
116. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol Med Microbiol 2007; 50: 157-164 [PMID: 17521355 DOI: 10.1111/j.1574-695X.2007.00258.x]
117. Chow J, Mazmanian SK. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 2010; 7: 265-276 [PMID: 20413095 DOI: 10.1016/j.chom.2010.03.004]
118. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402 [PMID: 10746728 DOI: 10.1038/35006081]
119. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-636 [PMID: 15579481 DOI: 10.1093/carcin/bgh349]
120. Rupnow MF, Shachter RD, Owens DK, Parsonnet J. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine 2001; 20: 879-885 [PMID: 11738753 DOI: 10.1016/S0264-410X(01)00401-7]
121. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics 2007; 119: e754-e759 [PMID: 17325213 DOI: 10.1542/peds.2006-2196]
122. Shahinian ML, Passaro DJ, Swerdlow DL, Mintz ED, Rodriguez M, Parsonnel J. Helicobacter pylori and epidemic Vibrio cholerae O1 infection in Peru. Lancet 2000; 355: 377-378 [PMID: 10665561 DOI: 10.1016/S0140-6736(99)05143-0]
123. Bhan MK, Bahl R, Sazawal S, Sinha A, Kumar R, Mahalanabis D, Clemens JD. Association between Helicobacter pylori infection and increased risk of typhoid fever. J Infect Dis 2002; 186: 1857-1860 [PMID: 12447776 DOI: 10.1086/345762]
124. de Vries R, Klok RM, Brouwers JR, Postma MJ. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health. Vaccine 2009; 27: 846-852 [PMID: 19084566 DOI: 10.1016/j.vaccine.2008.11.081]
125. Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis 2009; 200: 1311-1317 [PMID: 19751153 DOI: 10.1086/605845]
126. Velin D, Narayan S, Bernasconi E, Busso N, Ramelli G, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Michetti P, So A. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.